Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
about
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoringCognitive-behavioral therapy for adolescent depression and suicidalityTreatment of recurrent depressionPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsInterventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsNewer generation antidepressants for depressive disorders in children and adolescentsPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsInterventions for preventing relapse and recurrence after the first episode of a depressive disorder in young peopleSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescentsBenefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxineSuicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxineDevelopment and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment ProfileTreat depressed teens with medication and psychotherapyPrevention of depression in at-risk adolescents: a randomized controlled trialPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeSelective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trialCharacteristics and Components of the TADS CBT ApproachSuicide Prevention Interventions for Sexual & Gender Minority Youth: An Unmet NeedOutcome domains in child mental health research since 1996: have they changed and why does it matter?Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and NutritionTreatment of anxiety and depression in the preschool periodPharmacotherapy for anxiety disorders in children and adolescentsPsychological interventions for mental health disorders in children with chronic physical illness: a systematic reviewThe treatment of depressive disorders in children and adolescentsEnhancing the developmental appropriateness of treatment for depression in youth: integrating the family in treatmentAdvancing Science Through Collaborative Data Sharing and SynthesisTrajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.Understanding complexity in the human brain.Concurrent trajectories of change in adolescent and maternal depressive symptoms in the TORDIA study.The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depressionFluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.Paradoxical anxiogenic response of juvenile mice to fluoxetineThe role of peer rejection in adolescent depression.Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled supMultiple imputation for harmonizing longitudinal non-commensurate measures in individual participant data meta-analysis.Diagnosis of depression among adolescents--a clinical validation study of key questions and questionnaire.Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.Functional interpretations of sadness, stress and demoralization among an urban population of low-income mothers.Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.
P2860
Q21202071-E7F68285-8B2A-49AE-A1B5-DC5B54CE7920Q22252299-0441299C-693D-4F1E-A644-F0A6E7804B77Q22305946-27F06933-D1CF-46C1-9BAE-F72B5BB1A899Q24187748-6C5F3C7E-8A0F-4BCE-ACE4-7FB37588E33CQ24197563-A4F36C42-7F52-4593-8A71-43BEA0CB3932Q24202831-66B6572A-F817-42BB-9D70-41B7230406ECQ24202873-2763A3E0-1855-440C-9C8A-D10EB9D693EBQ24241474-684DF90D-886B-4E89-A462-25A5976B456BQ24242560-655B51A7-496C-4C9F-B54E-2F84E128E2CFQ24244127-6EFF8319-68C0-4784-9104-08F00ABCD7A7Q24607720-3AD95246-F456-4160-94F3-3C3BBEE86D57Q24612175-FA39795D-4A89-4F6B-B130-48D6ADF57977Q24623483-E9F4A041-4148-44A0-AE93-2858980C455EQ24635337-0BE262EA-0BE6-486E-905F-54942997ABF2Q24642033-995FFE7D-DAFA-406E-B9A5-174CF10E0924Q24648097-29EB3094-459F-4DDA-848F-2C5E180A86E5Q24669688-5E010C8D-4D69-41E3-B919-3981B48630DCQ24670955-7110C70C-8BA6-4E8A-B039-893949709BABQ26746176-F3D0790F-579D-466C-8257-4EAE2BE2151FQ26822028-B37DE14C-94AC-430A-AED2-DB8A77BA0991Q26824846-18274C15-2138-44B4-B691-547B96067EFBQ26827211-C9042343-83E5-4F4B-A981-F4E0131E4FD2Q26853715-E8977B3B-EB7A-4922-99E8-26A54DF323A1Q26864893-F97DC6DE-B0BB-46DD-8EFA-3DBE1B554C73Q26998760-A4CC77D9-4811-4AB9-82F7-BA412D08B621Q27021667-A2EB57DC-810E-442C-B5F4-77C93A863297Q28661625-AC910C10-53EC-4C14-86D1-C76502C115A3Q30353906-ECE65B7B-4771-4159-8069-591B46BB4F1FQ30401906-1FEB1723-E960-442B-AB1B-9E44E351CEB8Q30406130-2B8834AD-CF49-4C8A-BB33-326CFCB2C8A3Q30472596-269E8E31-6F12-4B5B-8238-712414AD267DQ30477109-2A463B34-CE0D-48C9-B139-DF7F286A94A5Q30491364-1DA29D9A-F951-47E6-A09F-F449DD100E24Q30618172-64DF3128-2983-4BBE-B073-B9FFA736D798Q30837059-DADF46C8-F1C5-42F0-ADF6-024230E6B67FQ30975676-27EE8F4D-D88A-4236-A554-5112D837360DQ33290655-7BBD5519-B6C5-4069-8B64-CA0752239915Q33350235-F105CEDA-A644-4521-839C-B92753E32476Q33401289-CEF70FE9-87FC-4C59-8625-9F3A03FD68C3Q33411020-2BBF6EC7-35D1-4AC0-A05C-090768BF2790
P2860
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@ast
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@en
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@nl
type
label
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@ast
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@en
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@nl
prefLabel
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@ast
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@en
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@nl
P2093
P356
P1476
Fluoxetine, cognitive-behavior ...... ) randomized controlled trial.
@en
P2093
Barbara Burns
Benedetto Vitiello
Joanne Severe
John Curry
John Fairbank
John March
Karen Wells
Marisa Domino
Stephen Petrycki
Steven McNulty
P304
P356
10.1001/JAMA.292.7.807
P407
P577
2004-08-01T00:00:00Z